	December 31,
	2020		2019
Revolving credit facility	$	89.8	$	131.3
Other obligations		4.3		5.5
Total debt		94.1		136.8
Less current portion		1.7		1.7
Long-term debt	$	92.4	$	135.1

Credit Facility— In July 2017, the Company amended and extended its asset-based senior secured revolving credit facility (“credit facility”) with Wells Fargo Capital Finance, Bank of America and JPMorgan Chase. The amendment, among other things, increased the borrowing capacity from $160 million to $250 million, reduced the interest rate, reduced the minimum fixed charge coverage ratio (“FCCR”) and extended the maturity to July 14, 2022. The amended facility may be increased to $300 million, through an uncommitted $50 million accordion feature, subject to certain conditions. Borrowing availability under the credit facility is based on eligible accounts receivable, inventory and real estate. The real estate component of the borrowing base amortizes monthly over 12.5 years on a straight-line basis. Borrowings under the credit facility are collateralized by substantially all of the Company’s assets, and the Company is subject to certain operating limitations applicable to a loan of this type, which, among other things, place limitations on indebtedness, liens, investments, mergers and acquisitions, dispositions of assets, cash dividends and transactions with affiliates. The Company pays a commitment fee for unused capacity of 0.25% per annum.

At December 31, 2020, under the credit facility, the Company had revolving credit borrowings of $89.8 million outstanding at a weighted average interest rate of 1.46% per annum, letters of credit outstanding totaling $3.2 million, primarily for health and workers’ compensation insurance, and $59.0 million of additional committed borrowing capacity based on existing collateral levels. The Company had $3.3 million of financing leases and $1.0 million of other obligations outstanding at December 31, 2020 at a weighted average borrowing rate of 5.21% and 6.11%, respectively.

At December 31, 2019, under the credit facility, the Company had revolving credit borrowings of $131.3 million outstanding at a weighted average interest rate of 3.35% per annum, letters of credit outstanding totaling $3.2 million, primarily for health and workers’ compensation insurance, and $31.5 million of additional committed borrowing capacity. In addition, the Company had $4.2 million of financing leases and $1.3 million of other obligations outstanding at December 31, 2019 at a weighted average rate of 5.42% and 6.11%.

The sole financial covenant in the credit facility is the minimum FCCR of 1.00:1.00, which must be tested by the Company if the excess borrowing availability falls below an amount in the range of $17.5 million to $31.3 million, depending on our borrowing base. For 2020 the minimum FCCR was not required to be tested as excess borrowing

availability was greater than the minimum threshold, but if the Company had been unable to maintain excess borrowing availability of more than the applicable amount in the range of $17.5 million to $31.3 million as required, the Company would not have met the minimum required FCCR early in the year, although it did meet the ratio at December 31, 2020. The FCCR must also be tested on a pro forma basis prior to consummation of certain significant business transactions outside the ordinary course of our business, as defined in the agreement.

Maturities—At December 31, 2020, the aggregate scheduled maturities of debt were as follows (in millions):

2021	$	1.7
2022		91.2
2023		0.9
2024		0.2
2025		0.1
Total	$	94.1

The fair value of long-term debt, as calculated using the aggregate cash flows from principal and interest payments over the life of the debt, was approximately $93.8 million and $133.0 million at December 31, 2020 and 2019, respectively, based upon a discounted cash flow analysis using current market interest rates.